Babies born prematurely who require treatment to prevent blindness from retinopathy of prematurity (ROP) could be treated with a dose of Avastin (bevacizumab) that is a fraction of the dose commonly used for ROP currently.
Click here for original story, Very low-dose Avastin effective for preventing blindness in preterm infants
Source: ScienceDaily